Abstract

BackgroundAnti-TNF drugs are an effective therapy for patients (pts) with rheumatoid arthritis (RA) but are associated with an increased incidence of serious infectious events (SIEs). We have previously identified baseline...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call